A new #LongCovid clinical trial is enrolling for bezisterim, an investigational anti-inflammatory drug that crosses the blood-brain barrier. It has been studied in neurological & neurodegenerative disorders, including Alzheimer’s & Parkinson’s. 1/ - ThreadSky

About ThreadSky

patientled.bsky.social • 5 days ago

A new #LongCovid clinical trial is enrolling for bezisterim, an investigational anti-inflammatory drug that crosses the blood-brain barrier.

It has been studied in neurological & neurodegenerative disorders, including Alzheimer’s & Parkinson’s. 1/

Comments

patientled.bsky.social•5 days ago

Eligibility:

-18-64 years old
-Have brain fog & fatigue attributed to a COVID infection
-Have symptoms for at least 3 months, but not longer than 24 months
-Not diagnosed with ADHD prior to the index COVID infection
-Not taking Naltrexone within 30 days prior to the first visit

2/

noahsbarks.com•5 days ago

why the cutoff at 24 months of symptoms? is this just to isolate variables in the trial?

patientled.bsky.social•5 days ago

There are many sites across the US hosting this trial! Contact a study site to determine if you're eligible.

More US study sites will be added over the next few months. 🔗 https://addresslongcovid.com/sites/ 3/

defeline.bsky.social•1 day ago

They need West Coast representation!!

chunky-baby.bsky.social•5 days ago

Anything in Washington right now?

andreastudiescovid.bsky.social•4 days ago

A similar study is underway, with results expected next year.

https://www.neurologylive.com/view/newly-initiated-address-lc-trial-to-test-bezisterim-treatment-neurological-symptoms-long-covid

andreastudiescovid.bsky.social•4 days ago

Finally a study in my area, but I'm 65, have ADHD, and have had long COVID for nearly five and a half years. Fauci wasn't kidding when he said some of us are just going to fall by the wayside.

Posting Rules

Be respectful to others
No spam or self-promotion
Stay on topic
Follow Bluesky's terms of service

Comments

Posting Rules

Reply